PTAB challenges

Proceedings overview

As of May 29, 2026, there are no AIA trial proceedings on file for US patent 7577099. This means the patent has not been challenged through Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) proceedings. For a defendant, this indicates that the patent claims have not been subjected to PTAB scrutiny, and an IPR or other AIA trial proceeding remains a viable defensive option if facing assertion.

Strategic summary

Currently, all claims of US patent 7577099 (claims 1-3) are untested by PTAB proceedings. The absence of any AIA trial activity means there is no estoppel landscape established under 35 U.S.C. § 315(e)(2). Therefore, a defendant facing assertion of this patent would not be barred from raising any prior-art grounds that could reasonably have been raised in an IPR. The lack of PTAB challenges could suggest that the patent has not been extensively asserted, or that prior art challenges through other avenues (e.g., district court litigation) have not yet led to PTAB filings.

Recommended next steps

If facing assertion of US patent 7577099, the absence of PTAB activity suggests that all claims (1-3) remain open to challenge via an AIA trial proceeding. An initial step would be to conduct a thorough prior art search to identify potential grounds for an Inter Partes Review (IPR). Since the patent was granted on August 18, 2009, and filed on April 6, 2006, IPR would be the appropriate proceeding type, as PGR and CBM generally apply to patents filed or issued after specific dates in the AIA.

Proceedings overview

As of May 29, 2026, there are no AIA trial proceedings on file for US patent 7577099. This indicates that the patent has not been subjected to challenges such as Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) proceedings. For a defendant, this means the patent's claims have not been examined by the PTAB, leaving an AIA trial as a potential avenue for challenging validity.

Strategic summary

All three claims (claims 1, 2, and 3) of US patent 7577099 remain untested by PTAB proceedings. Consequently, there is no established estoppel under 35 U.S.C. § 315(e)(2) for any petitioner or their privies. This implies that any prior art grounds, including those that could have been reasonably raised in an AIA trial, are still available for a defendant to assert. The lack of PTAB activity could signify that the patent has not been heavily litigated or targeted by defensive aggregators.

Recommended next steps

Given the absence of PTAB activity on US patent 7577099, a defendant facing assertion should consider initiating an Inter Partes Review (IPR) if a strong prior art position can be developed. Since the patent's priority date precedes the effective dates for PGR and CBM, IPR is the most relevant AIA trial option. A thorough prior art search would be crucial to identify printed publications or patents that anticipate or render obvious the claims of 7577099. The USPTO's PTAB E2E system (for searching decisions) and the Federal Circuit's website (for appeals) would be consulted if any future proceedings arise.